Document is current
Any future updates will be listed below
-
Authors
Pierce, Sarah E. http://orcid.org/0000-0002-9145-9559
Granja, Jeffrey M.
Corces, M. Ryan
Brady, Jennifer J.
Tsai, Min K. http://orcid.org/0000-0003-4732-4259
Pierce, Aubrey B.
Tang, Rui
Chu, Pauline
Feldser, David M. http://orcid.org/0000-0001-5975-864X
Chang, Howard Y. http://orcid.org/0000-0002-9459-4393
Bassik, Michael C. http://orcid.org/0000-0001-5185-8427
Greenleaf, William J. http://orcid.org/0000-0003-1409-3095
Winslow, Monte M. http://orcid.org/0000-0002-5730-9573
- License Information
-
More Information
Article History
Received: 20 July 2020
Accepted: 5 July 2021
First Online: 2 August 2021
Competing interests
: W.J.G. and H.Y.C. are consultants for 10x Genomics, which has licensed IP associated with ATAC–seq. W.J.G. has additional affiliations with Guardant Health (consultant) and Protillion Biosciences (co-founder and consultant). M.M.W. is a co-founder of, and holds equity in, D2G Oncology, Inc. H.Y.C. is a co-founder of Accent Therapeutics, Boundless Bio, and a consultant for Arsenal Biosciences and Spring Discovery. The remaining authors declare no competing interests.
